Skip to main content
Log in

Expression and purification of soluble recombinant Human Endostatin in Escherichia coli

  • Research Paper
  • Published:
Biotechnology and Bioprocess Engineering Aims and scope Submit manuscript

Abstract

Endostatin, a 20 kDa C-terminal fragment of collagen XVIII, is a specific inhibitor of endothelial cell proliferation and angiogenesis. In the present study, we produced soluble and biologically active recombinant human endostatin (rhEndostatin) in Escherichia coli by expressing via fusion with solubility-promoting peptides and optimizing the expression conditions. The rhEndostatin was expressed via fusion with glutathione S-transferase (GST) and NusA protein, respectively. It revealed that NusA protein enhanced the production of soluble rhEndostatin; but GST didn’t. By optimizing the expression conditions, the production of soluble NusA-rhEndostatin fusion protein was about 50% of total cellular proteins and about 90% of the products appeared in the cellular supernatant fraction. The soluble NusA-rhEndostatin fusion protein was purified by one-step hydrophobic interaction chromatography and NusA was removed by thrombin. Then rhEndostatin was purified by affinity chromatography and gel filtration chromatography. As a result, a simple and economical purification procedure for rhEndostatin isolation was obtained. The biological activity of the rhEndostatin was demonstrated in vitro using a human vascular endothelial cells (HuVECs) proliferation assay. Our study provides a feasible and convenient approach to produce soluble and biologically active rhEndostatin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. O’Reilly, M. S., T. Boehm, and J. Folkman (1997) Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277–285.

    Article  Google Scholar 

  2. Boehm, T., M. S. O’Reilly, K. Keough, J. Shiloach, R. Shapiro, and J. Folkman (1998) Zinc-binding of endostatin is essential for its antiangiogenic activity. Biochem. Biophys. Res. Commun. 252: 190–194.

    Article  CAS  Google Scholar 

  3. Ding, Y. H., K. Javaherian, K. M. Lo, R. Chopra, T. Boehm, J. Lanciotti, B. A. Harris, Y. Li, R. Shapiro, E. Hohenester, R. Timpl, J. Folkman, and D. C. Wiley (1998) Zinc-dependent dimmers observed in crystals of human endostatin. Proc. Natl. Acad. Sci. USA 95: 10443–10448.

    Article  CAS  Google Scholar 

  4. Sasaki, T., N. Fukai, K. Mann, W. Göhring, B. R. Olsen, and R. Timpl (1998) Structure, function and tissue forms of the Cterminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J. 17: 4249–4256.

    Article  CAS  Google Scholar 

  5. Boehm, T., J. Folkman, and M. S. O’Reilly (1997) Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390: 404–407.

    Article  CAS  Google Scholar 

  6. Sudhakar, A., H. Sugimoto, and C. Q. Yang (2003) Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by αVβ3 and α5β1 integrins. Proc. Natl. Acad. Sci. USA 100: 4766–4771.

    Article  CAS  Google Scholar 

  7. Chura-Chambi, R. M., P. H. Tornieri, P. J. Spencer, P. A. Nascimento, M. B. Mathor, and L. Morganti (2004) High-level synthesis of recombinant murine endostatin in Chinese hamster ovary cells. Protein Expr. Purif. 35: 11–16.

    Article  CAS  Google Scholar 

  8. Dhanabal, M., R. Volk, R. Ramchandran, M. Simons, and V. P. Sukhatme (1999) Cloning, expression, and in vitro activity of human endostatin. Biochem. Biophys. Res Comm. 258: 345–352.

    Article  CAS  Google Scholar 

  9. Violand, B. N. and E. I. Harding (1999) Method of producing mouse and human endostatin. US Patent 6,653,098.

  10. Xu, H. M., G. Y. Zhang, X. D. Ji, L. Cao, L. Shu, and Z. C. Hua (2005) Expression of soluble, biologically active recombinant human endostatin in Escherichia coli. Protein Expr. Purif. 41: 252–258.

    Article  CAS  Google Scholar 

  11. You, W. K., S. H. So, L. Hyosil, S. Y. Park, M. R. Yoon, S. I. Chang, H. K. Kim, Y. A. Joe, Y. K. Hong, and S. I. Chung (1999) Purification and characterization of recombinant murine endostatin in Escherichia coli. Exp. Mol. Med. 31: 197–202.

    CAS  Google Scholar 

  12. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248–254.

    Article  CAS  Google Scholar 

  13. Sun, Z., W. Lu, Y. Tang, J. Zhang, J. Chen, H. Deng, X. Li, and J. N. Liu (2007) Expression, purification, and characterization of human urodilatin in Escherichia coli. Protein Expr. Purif. 55: 312–318.

    Article  CAS  Google Scholar 

  14. Wohlkönig, A., M. Sénéchal, F. Dewitte, K. Backers, C. Erneux, and V. Villeret (2007) Expression and purification in high yield of a functionally active recombinant human Type I inositol (1,4,5)P3 5-phosphatase. Protein Expr. Purif. 55: 69–74.

    Article  Google Scholar 

  15. Yan, B., J. T. Zhou, J. Wang, C. H. Du, H. M. Hou, Z. Y. Song, and Y. M. Bao (2004) Expression and characteristics of the gene encoding azoreductase from Rhodobacter sphaeroides AS1.1737. FEMS Microbiol. Lett. 236: 129–136.

    Article  CAS  Google Scholar 

  16. Niiranen, L., S. Espelid, C. R. Karlsen, M. Mustonen, S. M. Paulsen, P. Heikinheimo, and N. P. Willassen (2007) Comparative expression study to increase the solubility of cold adapted Vibrio proteins in Escherichia coli. Protein Expr. Purif. 52: 210–218.

    Article  CAS  Google Scholar 

  17. Davis, G. D., C. Elisee, D. M. Newham, and R. G. Harrison (1999) New fusion protein systems designed to give soluble expression in Escherichia coli. Biotechnol. Bioeng. 65: 382–388.

    Article  CAS  Google Scholar 

  18. Bessette, P. H., F. Aslund, J. Beckwith, and G. Georgiou (1999) Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm. Proc. Natl. Acad. Sci. USA 96: 13703–13708.

    Article  CAS  Google Scholar 

  19. Dhanabal, M., R. Ramchandran, R. Volk, I. E. Stillman, M. Lombardo, M. L. Iruela-Arispe, M. Simons, and V. P. Sukhatme (1999) Endostatin: Yeast production. Mutants and antitumor effect in renal cell carcinoma. Cancer Res. 59: 189–197.

    CAS  Google Scholar 

  20. Hohenester, E., T. Sasaki, R. B. Olsen, and R. Timpl (1998) Crystal structure of the angiogenesis inhibitor endostatin at 1.5 A resolution. EMBO J. 17: 1656–1664.

    Article  CAS  Google Scholar 

  21. Miosge, N., T. Sasaki, and R. Timpl (1999) Angiogenesis inhibitor endostatin is a distinct component of elastic fibers in vessel walls. FASEB J. 13: 1743–1750.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cuihong Du.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Du, C., Yi, X. & Zhang, Y. Expression and purification of soluble recombinant Human Endostatin in Escherichia coli . Biotechnol Bioproc E 15, 229–235 (2010). https://doi.org/10.1007/s12257-009-0100-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12257-009-0100-5

Keywords

Navigation